Cerus Corporation CERS announced today that it has signed a two-year
purchase agreement with two regional Swiss Red Cross Blood Services for
deployment of the INTERCEPT Blood System for plasma in Lausanne and Zurich.
These two pilot centers supply an estimated 15,000 plasma units annually.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in